Long-Term Prognosis of Staphylococcus aureus Bacteremia

Mortality risk is elevated for longer than the usual 30 days of follow-up and is especially high for infections involving methicillin-resistant strains.

Researchers examining outcomes among patients with Staphylococcus aureus bacteremia have usually focused on 30-day or in-hospital mortality. But how do surviving patients fare after discharge home or to a long-term care facility? Two research groups recently examined this issue.

Wolkewitz and colleagues conducted a cohort analysis involving 3132 adults who were admitted to Ninewells Hospital in Scotland between January 2005 and September 2006. Sixty of the patients developed S. aureus bacteremia while hospitalized; the causative organism was methicillin-sensitive (MSSA) in 26 patients and methicillin-resistant (MRSA) in 34. Across the entire cohort, the in-hospital mortality rate was 6.5% and the 90-day mortality rate was 15.8%. The 90-day m…

Reviewing Author

Thomas Glück, MD

Disclosures

Editorial BoardsConsilium Infectiorum by InfectoPharm, Infection

Thomas Glück, MD

Disclosures

Editorial BoardsConsilium Infectiorum by InfectoPharm, Infection